NewsRoom Articles - Page 36 of 115 - CanadianCannabisWire

ThursdayJul 29, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) Globally Unlocking Data in the Complete Therapeutic Plant Lifecycle

Providing a holistic approach to therapeutic plant treatment by unlocking data from seed to consumption RYAH Group is providing needed dosing devices globally to drive innovation and deliver cutting edge plant-based medical solutions globally With over 200k registered users, RYAH Group is one of the largest plant-based medicine databases in the world and regularly releases and shares valuable insights collected RYAH Group (CSE: RYAH), formerly RYAH Medtech, is leading the way forward by providing a holistic approach to therapeutic plant treatment by unlocking the data in the complete plant lifecycle (seed to consumption). Known for its high-quality information and digital…

TuesdayJul 27, 2021 9:30 am

Flora Growth Corp. (NASDAQ: FLGC) Is ‘One to Watch’

Flora Growth is uniquely positioned to achieve revenue growth, with a balance sheet supported by two successful financings and the recent launch of multiple operating divisions The company boasts a robust M&A pipeline featuring strategic targets with near-term revenue growth opportunities and global distribution channels Flora Growth is led by an exceptional management team featuring cannabis, CPG, and capital markets experts who have raised more than $3 billion in combined public financings The company’s brand portfolio features 280+ products, 70+ medical and cosmetic licenses, and 2,500+ points of distribution across Latin America and the U.S. Flora Growth has a healthy…

TuesdayJul 27, 2021 9:30 am

The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Finalizes Distribution Agreement with Largest Food Retailer in the Mid-Atlantic

WTER’s distribution agreement calls for Giant Food to carry select WTER Alkaline88(R) and A88 Infused(R) offerings The distributor will offer WTER beverages in all 164 locations. Giant Food serves market of 60 million people with over $5 billion in sales. In an move illustrative of its continued commitment to expansion and growth, The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) announced that it has partnered with Giant Food, the largest food retailer in the Mid-Atlantic region. The distribution agreement calls for Giant Food to carry select WTER Alkaline88 and A88 Infused offerings in all locations. “This is our biggest win to date…

TuesdayJul 27, 2021 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes VIRAL-A20-3 Pharmacokinetic Study on DehydraTECH(TM) Enabled Colchicine

The study indicated enhanced delivery of colchicine using the company’s proprietary DehydraTECH(TM) technology Lexaria collaborates with the National Research Council (“NRC”), Canada’s leading research and technology organization The company has 20 patents granted and over 50 pending patents in over 40 countries around the world The global market for advanced drug delivery systems was valued at $231 billion in 2020 and is expected to grow to $310 billion by 2025 Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that the tolerability and pharmacokinetic study entitled VIRAL-A20-3 was completed and yielded positive results. The study demonstrated…

FridayJul 23, 2021 9:30 am

The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Record Revenue Streak Continues

The company’s FY 2021 numbers show record revenue of $46 million, a 20% year-over-year increase WTER issues guidance for the full FY 2022 of $62 million, which would represent year-over-year growth of 35% In addition to significant financial highlights, the FY 2021 report noted key operational milestones As The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER) continues its focus on consistent growth and expansion, its financial reports are tangible proof of the success of those efforts. The company’s FY 2021 numbers show record revenue of $46 million, a 20% year-over-year increase for the country’s largest independent alkaline water company (https://cnw.fm/1Ymfg).…

FridayJul 23, 2021 9:00 am

Popularity of Delta-8 THC and Novel Premium Strains Reveal Emerging Consumer Markets for Genetics-Focused Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM)

Delta-8 THC among many new strains gaining popularity with consumers in rapidly growing cannabis market Studies suggest optimized cannabinoid profiles play role in efficacy, strains can be optimized for recreational and medical uses Pac Roots leverages genetics-first approach to produce superior strains with optimized cannabinoid profiles, resistance to fungus, maximum yields With promises of pain relief, minimal paranoia and a milder euphoric effect, Delta-8 THC is emerging as a gentler alternative to traditional marijuana that is high in Delta-9 THC - the psychoactive component found in conventional cannabis (https://cnw.fm/t6wkl). Through its genetics-first cultivation approach, Pac Roots Cannabis (CSE: PACR) (OTCQB:…

FridayJul 23, 2021 9:00 am

Test Results Boost Lexaria Bioscience Corp. (NASDAQ: LEXX) Potential in Enhancing Antiviral Drugs

Lexaria Bioscience has completed a study conducted by Canada’s National Research Council for the use of its DehydraTECH IP with five drugs known to target the main protease associated with SARS-CoV-2 infection, including remdesivir The SARS-CoV-2 infection is the underlying force behind the COVID-19 pandemic that has killed millions of people during the past year and currently has begun trending toward a rising infection rate again DehydraTECH technology helps drugs gain better bioavailability through quick and effective introduction into patients’ bloodstreams using oral administration as opposed to injections The recent study results demonstrate that DehydraTECH-processed remdesivir, ebastine, bepridil, rupintrivir, and…

WednesdayJul 21, 2021 9:00 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Looks to Leverage Position in Growing Infused-Cannabis Space

New numbers project that cannabis beverage market will reach $2.8 billion by 2025 Increasing demand for the health and wellness drinks is contributing to market growth BevCanna’s scalable, flexible manufacturing process provides white label solutions for third-party companies A new report that forecasts the cannabis beverage market will grow at 17.85% CAGR by 2025 has companies such as BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) anticipating increased numbers as well (https://cnw.fm/O7FOa). A leader in the space, BevCanna is looking to leverage its position in the growing market as a white label manufacturer of infused-cannabis beverage brands. According to a…

TuesdayJul 20, 2021 9:00 am

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Leverages Genetic Technology to Produce First-In-Class Medical Grade Cannabis

Science continues to substantiate use of cannabis for pain relief, epileptic seizure control Research suggests strains with optimized cannabinoid profiles are more effective PACR produces premium top-quality strains cultivated using genetics-first approach to optimize cannabinoid profiles Genetic cultivation techniques allow selection for specific growing environments, maximum yields With a growing list of use cases spanning pain relief to seizure control, the medicinal use of cannabis goes back thousands of years (https://cnw.fm/GvpWP). Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), a Canadian cannabis company, leverages a genetics-focused approach to producing premium-quality strains with optimum cannabinoid profiles that are prized among…

MondayJul 19, 2021 11:25 am

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Partners with Agora Internet Relations Corp. for Its Marketing and Advertising

XPhyto partners with AGORA t to grow its brand and overall market share The agreement entails shares issued to AGORA on August 21, 2021 and December 31, 2021 at a price of $2.12 per share, subject to a hold period that ends on October 18, 2021 AGORA is known for its online marketing, conferences, broadcasting and investor relations services Its clients include CardioComm Solutions, Good Life Networks, Northern Sphere, Grizzly Discoveries and IntellaEquity Inc., among others XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) just announced that it is following through with its advertising agreement with AGORA Internet Relations Corp…

News and Publishing Service for Cannabis Related, Canadian Companies

Contact us: 512.354.7000